These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 22630053

  • 1. Immune regulatory gene polymorphisms as predisposing risk factors for the development of factor VIII inhibitors in Indian severe haemophilia A patients.
    Pinto P, Ghosh K, Shetty S.
    Haemophilia; 2012 Sep; 18(5):794-7. PubMed ID: 22630053
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A.
    Chaves D, Belisário A, Castro G, Santoro M, Rodrigues C.
    Int J Immunogenet; 2010 Apr; 37(2):79-82. PubMed ID: 20082647
    [Abstract] [Full Text] [Related]

  • 4. Impact of polymorphisms in genes involved in autoimmune disease on inhibitor development in Chinese patients with haemophilia A.
    Lu Y, Ding Q, Dai J, Wang H, Wang X.
    Thromb Haemost; 2012 Jan; 107(1):30-6. PubMed ID: 22116520
    [Abstract] [Full Text] [Related]

  • 5. Immune system polymorphisms and factor VIII inhibitor formation in Brazilian haemophilia A severe patients.
    Agostini D, Rosset C, Botton MR, Kappel DB, Vieira IA, Gorziza RP, Salzano FM, Bandinelli E.
    Haemophilia; 2012 Nov; 18(6):e416-8. PubMed ID: 22970761
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New associations: INFG and TGFB1 genes and the inhibitor development in severe haemophilia A.
    de Alencar JB, Macedo LC, de Barros MF, Rodrigues C, Shinzato AH, Pelissari CB, Machado J, Sell AM, Visentainer JE.
    Haemophilia; 2015 Jul; 21(4):e312-6. PubMed ID: 25930091
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.
    Coppola A, Santoro C, Tagliaferri A, Franchini M, DI Minno G.
    Haemophilia; 2010 Jan; 16 Suppl 1():13-9. PubMed ID: 20059564
    [Abstract] [Full Text] [Related]

  • 12. Genetic risk factors for inhibitors to factors VIII and IX.
    Oldenburg J, Pavlova A.
    Haemophilia; 2006 Dec; 12 Suppl 6():15-22. PubMed ID: 17123389
    [Abstract] [Full Text] [Related]

  • 13. The correlation between gene mutations and inhibitor development in patients with haemophilia A in southern Iran.
    Haghpanah S, Sahraiian M, Afrasiabi A, Enayati S, Peyvandi F, Karimi M.
    Haemophilia; 2011 Sep; 17(5):820-1. PubMed ID: 21371201
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitor development and management in three non-severe haemophilia A patients with T295A variant.
    Ivaskevicius V, Goldmann G, Horneff S, Marquardt N, Klein C, Albert T, Zeitler H, Oldenburg J.
    Hamostaseologie; 2014 Sep; 34 Suppl 1():S9-12. PubMed ID: 25382774
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characteristics of inhibitors in mild/moderate haemophilia A.
    Peerlinck K, Jacquemin M.
    Haemophilia; 2006 Dec; 12 Suppl 6():43-7. PubMed ID: 17123393
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.
    Lozier JN, Rosenberg PS, Goedert JJ, Menashe I.
    Haemophilia; 2011 Jul; 17(4):641-9. PubMed ID: 21362111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.